GAD2 and type 1 diabetes mellitus: In vitro studies have shown that GAD65 autoantibodies from patients with SPSD in most cases inhibit the enzymatic activity of GAD65 and reduce GABA synthesis in opposition to GAD65 autoantibodies from patients with T1DM, which have no such effect [201,202].